[HTML][HTML] Immunomodulatory role of mesenchymal stem cell therapy in liver fibrosis

P Liu, Y Qian, X Liu, X Zhu, X Zhang, Y Lv… - Frontiers in …, 2023 - frontiersin.org
Liver fibrosis is a fibrogenic and inflammatory process that results from hepatocyte injury and
is characterized by hepatic architectural distortion and resultant loss of liver function. There …

[HTML][HTML] Mesenchymal stem cell therapy for liver fibrosis/cirrhosis

Y Cao, C Ji, L Lu - Annals of translational medicine, 2020 - ncbi.nlm.nih.gov
Liver fibrosis represents a common outcome of most chronic liver diseases. Advanced
fibrosis leads to cirrhosis for which no effective treatment is available except liver …

[HTML][HTML] Current status and future prospects of mesenchymal stem cell therapy for liver fibrosis

Y Guo, B Chen, L Chen, C Zhang… - Journal of Zhejiang …, 2016 - ncbi.nlm.nih.gov
Liver fibrosis is the end-stage of many chronic liver diseases and is a significant health
threat. The only effective therapy is liver transplantation, which still has many problems …

[HTML][HTML] Liver disease: induction, progression, immunological mechanisms, and therapeutic interventions

SY Neshat, VM Quiroz, Y Wang, S Tamayo… - International journal of …, 2021 - mdpi.com
The liver is an organ with impressive regenerative potential and has been shown to heal
sizable portions after their removal. However, certain diseases can overstimulate its …

Liver disease and cell therapy: advances made and remaining challenges

S Khan, S Mahgoub, N Fallatah, PF Lalor… - Stem Cells, 2023 - academic.oup.com
The limited availability of organs for liver transplantation, the ultimate curative treatment for
end stage liver disease, has resulted in a growing and unmet need for alternative therapies …

Applications of mesenchymal stem cells in liver fibrosis: novel strategies, mechanisms, and clinical practice

M Zhu, T Hua, T Ouyang, H Qian… - Stem Cells International, 2021 - Wiley Online Library
Liver fibrosis is a common result of most chronic liver diseases, and advanced fibrosis often
leads to cirrhosis. Currently, there is no effective treatment for liver cirrhosis except liver …

[HTML][HTML] Use of mesenchymal stem cells to treat liver fibrosis: current situation and future prospects

S Berardis, PD Sattwika, M Najimi… - World journal of …, 2015 - ncbi.nlm.nih.gov
Progressive liver fibrosis is a major health issue for which no effective treatment is available,
leading to cirrhosis and orthotopic liver transplantation. However, organ shortage is a reality …

Mesenchymal stromal cells in hepatic fibrosis/cirrhosis: from pathogenesis to treatment

X Yang, Q Li, W Liu, C Zong, L Wei, Y Shi… - Cellular & Molecular …, 2023 - nature.com
Hepatic fibrosis/cirrhosis is a significant health burden worldwide, resulting in liver failure or
hepatocellular carcinoma (HCC) and accounting for many deaths each year. The …

[HTML][HTML] The application of mesenchymal stem cells in the treatment of liver diseases: mechanism, efficacy, and safety issues

Y Yang, Y Zhao, L Zhang, F Zhang, L Li - Frontiers in Medicine, 2021 - frontiersin.org
Mesenchymal stem cell (MSC) transplantation is a novel treatment for liver diseases due to
the roles of MSCs in regeneration, fibrosis inhibition and immune regulation. However, the …

Immunological basis of stem cell therapy in liver diseases

L Cui, Y Shi, Y Han, D Fan - Expert Review of Clinical Immunology, 2014 - Taylor & Francis
Unbalanced immune cell populations or immune cell infiltration of the liver can disrupt the
immune-privileged state of the liver, resulting in liver injury or fibrosis. Therefore, the …